Statements (48)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:skin
autoimmune disease |
gptkbp:affects |
gptkb:skin
elderly |
gptkbp:antibodyTarget |
BP230
BP180 |
gptkbp:associatedWith |
gptkb:DST
COL17A1 |
gptkbp:causedBy |
autoantibodies
|
gptkbp:complication |
sepsis
dehydration secondary infection |
gptkbp:diagnosedBy |
serology
skin biopsy direct immunofluorescence |
gptkbp:differentialDiagnosis |
gptkb:pemphigus_vulgaris
gptkb:epidermolysis_bullosa_acquisita dermatitis herpetiformis |
gptkbp:firstDescribed |
1953
|
gptkbp:hasEpidemiology |
slightly more common in males
more common in elderly |
gptkbp:hasOrphanetID |
ORPHA:792
|
gptkbp:hasUMLSID |
C0006287
|
https://www.w3.org/2000/01/rdf-schema#label |
bullous pemphigoid
|
gptkbp:ICD-10_code |
L12.0
|
gptkbp:MeSH_ID |
D001769
|
gptkbp:mortalityRate |
low
|
gptkbp:offersCourse |
chronic
relapsing |
gptkbp:OMIM |
112190
|
gptkbp:pathology |
subepidermal blister
|
gptkbp:prevalence |
rare
|
gptkbp:prognosis |
good with treatment
can be fatal if untreated |
gptkbp:riskFactor |
older age
neurological disease use of certain medications |
gptkbp:symptom |
itching
erythema blistering urticaria-like lesions |
gptkbp:treatment |
gptkb:dapsone
corticosteroids immunosuppressants topical steroids tetracyclines |
gptkbp:bfsParent |
gptkb:sitagliptin
|
gptkbp:bfsLayer |
6
|